<h1>Pharma maker highlights GMP-certified sterile injectables, expanded capacity, R&D centre and export-focused partnerships boosting commercial growth</h1> A pharmaceutical manufacturer reported participation at an international industry expo, promoting its sterile injectables and broad product portfolio and highlighting WHO-GMP, ISO and national regulator compliance. The company touted contract manufacturing relationships with major domestic firms, an approved R&D centre, and expanded manufacturing capacity since commercial launch in 2005. The release emphasizes regulatory certifications, export-oriented business development and proprietary R&D projects, suggesting strengthened commercial positioning and potential cross-border supply and licensing opportunities, while signalling ongoing regulatory obligations tied to quality standards, facility certifications and international market access.